A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00858078
First received: March 6, 2009
Last updated: May 9, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background:
- Mutations detected in the BRCA1 or BRCA2 genes have been show to produce very high risks of breast and ovarian cancer (as high as 90% and 60%, respectively), as well as accompanying risks for several other types of cancer. Women who have these genetic anomalies and who do not have cancer are aware of their high-risk status, which can have an effect on their ability to make decisions about personal choices and health care.
- Researchers are interested in learning more about how people who know their cancer risk status make decisions on personal relationships, family formation, and risk-reduction options.
Objectives:
- To study young women's experiences and decision-making processes regarding family history, genetic testing, couple relationships, family formation, and cancer risk management within the context of their experiences as BRCA1/2 mutation carriers.
Eligibility:
- Women between the ages of 18 and 35 years of age and older who have been identified as having a BRCA1 or BRCA2 mutation. Participants must be contemplating or have experienced couple relationships, family formation, and/or risk management and reduction.
- Participants must be willing to have their interviews digitally recorded
Design:
- Researchers will conduct between 30 and 50 telephone interviews of study participants. Each interview will be approximately 90 minutes in length. The interview consists of open-ended questions that ask about the participants and their experiences before, during, and after they underwent genetic testing for BRCA1/2.
- At least one focus group will be coordinated at a national conference for individuals who are aware of their genetically based cancer risk. If more than 25 individuals are interested in participating in the group, an additional focus group will be convened.
- No medical treatments are specifically offered as a part of this study.
| Condition |
|---|
|
Breast Cancer |
| Study Type: | Observational |
| Official Title: | A Qualitative Exploration of the Impact of Positive BRCA 1/2 Mutation Status on the Lives of Young Women |
Resource links provided by NLM:
Further study details as provided by National Institutes of Health Clinical Center (CC):
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
- INCLUSION CRITERIA:
- Participants must be biologically female
- Participants must have reached their 18th birthday but not have passed their 35th birthday
- Participants must be able to speak and understand English with a level of fluency sufficient for completion of the recorded telephone interview
- Participants must have completed genetic testing for BRCA1/2 and received a positive test result (i.e., a deleterious or disease-related mutation was identified).
- Participants must have experienced or be contemplating/planning couple relationship(s), formation of a family, and/or utilization of risk management/reduction strategies at some point.
EXCLUSION CRITERIA:
-Potential participants will be excluded from the study if they do not agree to have their interview or focus group contributions audio recorded.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00858078
Locations
| United States, Maryland | |
| National Cancer Institute (NCI), 9000 Rockville Pike | |
| Bethesda, Maryland, United States, 20892 | |
Sponsors and Collaborators
Investigators
| Principal Investigator: | Mark H Greene, M.D. | National Cancer Institute (NCI) |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00858078 History of Changes |
| Other Study ID Numbers: | 999909074, 09-C-N074 |
| Study First Received: | March 6, 2009 |
| Last Updated: | May 9, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Qualitative Research Semi-Structured Telephone Interview BRCA 1/2 Psychosocial/Behavioral Research |
Hereditary Cancer Risk BRCA BRCA1 Gene BRCA2 Gene |
Additional relevant MeSH terms:
|
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |
ClinicalTrials.gov processed this record on May 16, 2013